Study highlights biomarker for discontinuing anti-VEGF treatment A new study has demonstrated that a particular biomarker can be used to select which age-related macular degeneration (AMD) patients can discontinue their anti-VEGF therapy. Read More Myles HumeFebruary 14, 2020, 11:50 amFebruary 14, 2020
